臨床研究等提出・公開システム

Scientific Title	Lp(a) and Risks of Atherosclerotic Cardiovascular Diseases in Patients with Coronary Artery Disease who Received Lowering LDL-C Levels (Lp(a) and Residual Risks)
Public Title	Lp(a) and Residual Risks

Contact for Scientific Queries	Name	Kataoka Yu
	Affiliation	National Cerebral & Cardiovascular Center
	Address	Kishibe-shinmachi 6-1, Suita, Osaka
	Telephone	+81-6-6170-1070
	E-mail	yu.kataoka@ncvc.go.jp
Contact for Public Queries	Name	Yoshioka Yuko
	Affiliation	National Cerebral & Cardiovascular Center
	Address	Kishibe-shinmachi 6-1, Suita, Osaka
	Telephone	+81-6-6170-1070
	E-mail	yoshioka.yuko@ncvc.go.jp

Recruitment status	Recruiting

Anticipated date of first enrollment		Jan. 01, 2017
Actual date of first enrollment		Jan. 01, 2017
Target sample size		2000
Study Type		Observational
Study Design	allocation	non-randomized controlled trial
	masking	open(masking not used)
	control	uncontrolled control
	assignment	factorial assignment
	purpose	prevention purpose
Key inclusion & exclusion criteria	Inclusion Criteria	Patients with CAD who required PCI
	Exclusion Criteria	CAD attributable to non-atherosclerotic causes
	Age Minimum	No limit
	Age Maximum	No limit
	Gender	Both
Health Condition(s) or Problem(s) Studied		Coronary Artery Disease
Intervention(s)		N/A
Health Condition(s) Keyword		Coronary Artery Disease, LDL-C
Intervention(s) Keyword		N/A
Health Condition(s) Code		D003324
Intervention(s) Code		N/A
Primary Outcome(s)		The occurence of cardiovascular events
Secondary Outcome(s)		each component of MACE

Primary Sponsor	N/A

Secondary Sponsor

Secondary Sponsor

Name of Certified Review Board	National Cardiovascular Center Research Ethical Review Board
Address	Kishibe-shinmachi 6-1, Suita, Osaka, Osaka
Telephone	+81-6-6170-1070
E-Mail	rec-office-ac@ncvc.go.jp
Approval Status	Approval
Date of approval	Nov. 30, 2021

Plan to share IPD	No
Plan description	N/A

Secondary ID(s)	なし
Issuing Authority	N/A

Countries of Recruitment（Except Japan）	none